MPL has been related to hematological disorders, where its deficiency led to thrombocytopenia and bone marrow failure [87–89] and its enhanced functioning drove the development of myeloproliferative neoplasms [90–92]. This evidence concerns the gene MPL and myeloproliferative neoplasm.